RGDX Stock News 0.94 05/13/2014 18:09:28 Response Genetics (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Response Genetics (RGDX) 0.94 $RGDX

Response Genetics, Inc. Announces First Quarter 2014 Financial Results
GlobeNewswire - Thu May 08, 6:08AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced its consolidated financial results and business progress for the first quarter ended March 31, 2014.

Response Genetics, Inc. to Release First Quarter 2014 Financial Results and Host Conference Call on May 8, 2014
GlobeNewswire - Thu May 01, 3:12PM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, will announce its first quarter 2014 financial results and give an operational update in a press release to be issued before the market opens on Thursday, May 8, 2014. The company will host a conference call that same day at 8:30 a.m. EDT to discuss its financial results.

Response Genetics Enters Next Generation Sequencing Market With Proprietary Panel for Lung Cancer Developed by the Knight Cancer Institute at Oregon Health & Science University
GlobeNewswire - Mon Apr 21, 6:00AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced execution of an exclusive commercial agreement with the Knight Diagnostic Laboratories at Oregon Health & Science University (OHSU) for a proprietary next generation sequencing panel for lung cancer. The panel provides full gene sequencing of the actionable genes for lung cancer rather than detection only of so-called hot spots.

Upcoming Financial Results, Recent Investments and Agreements, and Expanded Collaborations - Analyst Notes on PerkinElmer, PAREXEL, WuXi, Response Genetics, and Foundation Medicine
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding PerkinElmer, Inc. (NYSE: PKI), PAREXEL International Corporation (NASDAQ: PRXL), WuXi PharmaTech (Cayman) Inc. (NYSE: WX), Response Genetics, Inc. (NASDAQ: RGDX), and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Technical Analysis on Top Gainers -- Research on Response Genetics, Gol Linhas Aereas Inteligentes, Gastar Exploration, and China Finance Online
PR Newswire - Fri Apr 04, 11:47AM CDT
The US markets saw a negative sentiment on Thursday, April 03, 2014, with the NASDAQ Composite closing at 4,237.74, down 0.91%, the Dow Jones Industrial Average ending the session flat at 16,572.55, and the S&P 500 edging 0.11% lower to finish the trading session at 1,888.77. The session saw a positive impact from Telecommunication Services, Energy and Utilities sectors along with a drag from Information Technology, Consumer Discretionary and Health Care sectors. A number of stocks saw large movements, including Response Genetics Inc. (NASDAQ: RGDX), Gol Linhas Aereas Inteligentes S.A. (NYSE: GOL), Gastar Exploration Inc. (NYSE MKT: GST) and China Finance Online Co. Ltd (NASDAQ: JRJC). Free technical research on RGDX, GOL, GST and JRJC can be downloaded upon signing up at:

Response Genetics (RGDX) in Focus: Stock Up 18.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 8:39AM CDT
Response Genetics, Inc was a big mover last session, as its shares rose over 18% on the day.

Kellogg Company Rises on Possible Takeover Suspicions; Amazon Releases Fire TV
ACCESSWIRE - Thu Apr 03, 11:21PM CDT
Kellogg Company (NYSE: K) - For an in-depth report on Kellogg Company follow: www.BullTrends.com/stockquote/K

Why Response Genetics (RGDX) Stock Is Soaring Today
at The Street - Thu Apr 03, 9:25AM CDT
Response Genetics (RGDX) surged on Thursday after the molecular diagnostic test developer announced contracts with six new provider networks, which increases its total membership to more than 174 million U.S. members. The contracts span 10 states and...

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
GlobeNewswire - Thu Mar 20, 6:01AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced its consolidated financial results and business progress for the fourth quarter and full year ended December 31, 2013.

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on March 20, 2014
GlobeNewswire - Wed Mar 12, 6:00AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, will announce its fourth quarter and year-end financial results for 2013 and give an operational update in a press release to be issued before the market opens on Thursday, March 20, 2014. The company will host a conference call that same day at 10:00 a.m. EDT to discuss its financial results.

Response Genetics, Inc. to Offer Expanded KRAS Mutation Test to Improve Treatment Decisions for Colorectal Cancer Patients
GlobeNewswire - Mon Mar 10, 6:13AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer today announced the commercial availability of its expanded KRAS assay, a mutation detection test that provides broader coverage of KRAS mutations, including those in regions of the gene not previously examined.

2 Health Care Stocks Under $10 to Trade
at The Street - Thu Feb 20, 5:00AM CST
These health care stocks under $10 were trading higher on Wednesday. Here's how to trade them now.

4 Stocks Under $10 Making Big Moves
at The Street - Fri Feb 14, 5:30AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Response Genetics Receives Third GSK Milestone Payment
GlobeNewswire - Mon Jan 27, 6:00AM CST
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has achieved its third milestone payment from GlaxoSmithKline LLC ("GSK" related to the issuance of a U.S. patent for detection of BRAF Mutations.

4 Under-$10 Health Care Stocks Moving Higher
at The Street - Fri Jan 17, 6:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Response Genetics, Inc. Announces Contracts With Two Additional Blue Cross Blue Shield Plans
GlobeNewswire - Wed Dec 18, 6:00AM CST
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has signed agreements with two new Blue Cross Blue Shield health plans.

Response Genetics, Inc. Announces Pricing of Underwritten Public Offering
GlobeNewswire - Fri Dec 13, 8:00AM CST
Response Genetics, Inc. (Nasdaq:RGDX) (the "Company" , a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, announced today it priced its previously announced underwritten public offering of 4,464,443 registered shares of its common stock, par value $0.01 per share, at a price of $1.20 per share. The Company plans to use the approximately $4,844,465 million in net proceeds of the offering for working capital and general corporate purposes. In connection with the offering, the Company has also granted the underwriter a 45-day option to purchase up to an additional 669,666 shares of common stock from the Company to cover over-allotments, if any.

Response Genetics, Inc. Announces Proposed Underwritten Public Offering
GlobeNewswire - Thu Dec 12, 3:33PM CST
Response Genetics, Inc. (Nasdaq:RGDX) (the "Company" , a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, announced today it intends to offer and sell registered shares of its common stock in an underwritten public offering. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes.

Response Genetics, Inc. Announces Four New Contracts With National PPO Networks
GlobeNewswire - Wed Nov 13, 6:00AM CST
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has recently closed four new payor contracts with national Preferred Provider Organization ("PPO" networks. The four new provider agreements are with:

Response Genetics, Inc. Announces $1.9 Million Registered Direct Offering
GlobeNewswire - Fri Sep 20, 7:45AM CDT
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has entered into definitive agreements with institutional investors for the sale of 932,805 shares of its common stock in a registered direct offering at $2.05 per share, the closing price on September 19, 2013. Gross proceeds of the offering, before deducting the placement agent fee and offering expenses, are expected to be approximately $1.9 million.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 19

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 88

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 150

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Stitch AI Targets Banking’s Hardest Automation Gap

Updated Category News Views 15

The flashy chatbot stuff is cheap; banking permission to act is not. That is why Stitch AI’s launch deserves more attention than another vendor slapping “agentic” on a slide deck and calling it transformation. Banks do not need a machine to summarize a policy document while everyone applauds the demo. They need technology that can touch real workflows without...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 81

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading

Top 5 Most Recently Viewed Articles

Kos Biotechnology Closes Record-Breaking $123M Fund

Updated Category News Views 80

Unprecedented Funding for Life Sciences When you hear about a $123 million fund popping up from nowhere, you stop and take notice. Kos Biotechnology Partners, a name that's bursting onto the scene with a hefty global life sciences fund, isn't messing around. Got their roots sinking into both New York and the ancient soil of Athens—this isn't just some flash-in-the-pan...

Continue Reading
Lyric Advances Battery Technology with Innovative Equipment

Updated Category News Views 149

Lyric's Innovative Contributions in Battery Technology Recently, Lyric successfully shipped its first solid-state battery front-end equipment to a customer, marking a significant milestone in their ongoing advancements in battery production technology. This achievement is a testament to Lyric's extensive experience and deep expertise in the field of solid-state batteries,...

Continue Reading
Danish Stock Market Update: Modest Decline and Notable Movers

Updated Category News Views 226

Danish Stock Market Sees Modest Decline The recent trading session in Denmark concluded with a slight downturn, marking a challenging day for investors as the OMX Copenhagen 20 index closed lower. The end of trading saw the index experiencing a reduction of 0.23%, setting a new six-month low. Such fluctuations can often reflect broader economic sentiments and provide...

Continue Reading
LiTHOS Group Advances Lithium Extraction with New Patent

Updated Category News Views 275

LiTHOS Group Innovates Lithium Extraction Techniques LiTHOS Group Ltd. (CBOE CA: LITS), a leader in sustainable lithium brine extraction, has achieved a significant milestone by securing a U.S. patent. The United States Patent and Trademark Office (USPTO) has allowed their patent for the "Electro-Pressure Membrane Method for Recovery and Concentration of Lithium from...

Continue Reading
Karbach Brewing: Your Ideal Venue for Memorable Celebrations

Updated Category News Views 378

Karbach Brewing: A New Venue for Unforgettable Corporate Events As the festive season approaches, businesses in Houston are searching for the ideal place to host their corporate holiday celebrations. Enter Karbach Brewing, a name that is rapidly becoming synonymous with memorable experiences. This brewery is not just about beer; it offers companies a distinctive setting...

Continue Reading